NASDAQ:RPRX | Free Cash Flow | Royalty Pharma plc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$718.23M
2025-12-31$827.15M
2025-03-31$596.08M
2024-12-31$742.53M
2024-03-31$664.64M
2023-12-31$772.63M
2023-03-31$1.03B
2022-12-31$569.93M
2022-03-31$460.27M
2021-12-31$489.96M
2021-03-31$526.1M
2020-12-31$565.67M
2020-03-31$471.1M
2019-12-31$478.43M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$2.49B
2024-12-31$2.77B
2023-12-31$2.99B
2022-12-31$2.14B
2021-12-31$2.02B
2020-12-31$2.03B
2019-12-31$1.67B
2018-12-31$1.62B